These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Antiphospholipid antibody syndrome and fetal outcome. Djelmis J; Radoncić E; Ivanisević M Acta Med Croatica; 2001; 55(3):123-30. PubMed ID: 11852731 [TBL] [Abstract][Full Text] [Related]
44. Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha. Bećarević M J Thromb Thrombolysis; 2017 Nov; 44(4):565-570. PubMed ID: 29027631 [TBL] [Abstract][Full Text] [Related]
45. Intravenous immunoglobulin therapy of antiphospholipid syndrome. Sherer Y; Levy Y; Shoenfeld Y Rheumatology (Oxford); 2000 Apr; 39(4):421-6. PubMed ID: 10817776 [TBL] [Abstract][Full Text] [Related]
46. Use of direct oral anticoagulants in antiphospholipid syndrome. Cohen H; Efthymiou M; Isenberg DA J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847 [TBL] [Abstract][Full Text] [Related]
47. Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome: A case series and systematic review of literature. Urban ML; Bettiol A; Serena C; Comito C; Turrini I; Fruttuoso S; Silvestri E; Vannacci A; Ravaldi C; Petraglia F; Emmi G; Prisco D; Mecacci F Autoimmun Rev; 2020 Sep; 19(9):102620. PubMed ID: 32682986 [TBL] [Abstract][Full Text] [Related]
48. Antiphospholipid syndrome: Diagnosis and management in the obstetric patient. Arslan E; Branch DW Best Pract Res Clin Obstet Gynaecol; 2020 Apr; 64():31-40. PubMed ID: 31704207 [TBL] [Abstract][Full Text] [Related]
49. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome. Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262 [TBL] [Abstract][Full Text] [Related]
50. Ophthalmologic manifestations in primary antiphospholipid syndrome patients: A cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature. Franco AMM; Medina FMC; Balbi GGM; Levy RA; Signorelli F Lupus; 2020 Oct; 29(12):1528-1543. PubMed ID: 32814509 [TBL] [Abstract][Full Text] [Related]
51. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Miyakis S; Lockshin MD; Atsumi T; Branch DW; Brey RL; Cervera R; Derksen RH; DE Groot PG; Koike T; Meroni PL; Reber G; Shoenfeld Y; Tincani A; Vlachoyiannopoulos PG; Krilis SA J Thromb Haemost; 2006 Feb; 4(2):295-306. PubMed ID: 16420554 [TBL] [Abstract][Full Text] [Related]
52. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome. de Jesús GR; Benson AE; Chighizola CB; Sciascia S; Branch DW Lupus; 2020 Oct; 29(12):1601-1615. PubMed ID: 32883160 [TBL] [Abstract][Full Text] [Related]